Form 4 for PCVX Vaxcyte, Inc.
Accepted 2021-12-28 00:00:00 ET · period of report 2021-12-27 · accession 0001209191-21-071375 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-28 | 2021-12-27 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.80 | +51.8K | 630.6K | +9% | +$93.0K |
| DM | 2021-12-28 | 2021-12-27 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -51.8K | 278.4K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-27 | M | A | 1,400 | $2.03 | 632,019 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-27 | M | A | 50,365 | $1.79 | 630,619 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2021-12-27 | M | D | 1,400 | $0.00 | 594,332 | D | $2.03 · — to 2028-07-23 | 1,400 Common Stock | (F2) 1/4 of the shares subject to the option vested on July 24, 2019, and 1/48 of the shares vest monthly thereafter. |
| 4 | Derivative | Stock Option (right to buy) | 2021-12-27 | M | D | 50,365 | $0.00 | 278,450 | D | $1.79 · — to 2027-05-17 | 50,365 Common Stock | (F1) The shares subject to the option are fully vested and exercisable. |